Author:
Alekseenko Irina V,Chernov Igor P,Kostrov Sergei V,Sverdlov Eugene D
Abstract
The failure of therapies directed at targets within cancer cells highlight the necessity for a paradigm change in cancer therapy. The attention of researchers has shifted towards the disruption of cancer cell interactions with the tumor microenvironment. A typical example of such a disruption is the immune checkpoint cancer therapy that disrupts interactions between the immune and the cancer cells. The interaction of cancer antigens with T cells occurs in the immunological synapses. This is characterized by several special features, i.e., the proximity of the immune cells and their target cells, strong intercellular adhesion, and secretion of signaling cytokines into the intercellular cleft. Earlier, we hypothesized that the cancer-associated fibroblasts interacting with cancer cells through a synapse-like adhesion might play an important role in cancer tumors. Studies of the interactions between cancer cells and cancer-associated fibroblasts showed that their clusterization on the membrane surface determined their strength and specificity. The hundreds of interacting pairs are involved in the binding that may indicate the formation of synapse-like structures. These interactions may be responsible for successful metastasis of cancer cells, and their identification and disruption may open new therapeutic possibilities.
Funder
Russian Science Foundation
Russian Foundation for Basic Research
Reference127 articles.
1. End of cancer-genome project prompts rethink
2. Systems biology and personalized medicine: To be or not to be?;Sverdlov;Ross. Fiziol. Zhurnal Im. IM Sechenova,2014
3. Genetic Surgery - A Right Strategy to Attack Cancer
4. The microcosmos of intratumor heterogeneity: the space-time of cancer evolution
5. Physical Sciences and Engineering Advances in Life Sciences and Oncology;Mallick,2015
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献